Definium Therapeutics, Inc.

DFTX ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
SCHEDULE 13G	Feb 17, 2026
SCHEDULE 13G	Feb 17, 2026
SCHEDULE 13G/A	Feb 13, 2026
4	Feb 5, 2026	4
4	Feb 5, 2026	4
4	Feb 5, 2026	4
4	Feb 5, 2026	4
4	Feb 5, 2026	4
4	Jan 29, 2026	4
3	Jan 29, 2026	3
8-K	Jan 29, 2026	8-K
8-K	Jan 12, 2026	8-K
4	Dec 29, 2025	4
4	Dec 29, 2025	4
4	Dec 29, 2025	4
144	Dec 29, 2025
144	Dec 29, 2025
144	Dec 29, 2025
SCHEDULE 13G/A	Nov 14, 2025
10-Q	Nov 6, 2025	10-Q
8-K	Nov 6, 2025	8-K
8-K	Oct 31, 2025	FORM 8-K
424B5	Oct 31, 2025	424B5
8-K	Oct 29, 2025	FORM 8-K
424B5	Oct 29, 2025	424B5

← Newer Page 4 of 21 · 503 filings Older →